PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for...

Field Trip Receives Notice of Allowance for US Patent Application Covering...

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel...

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted...

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Psychedelic Research and Clinical Trials in 2021

Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development...

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

Stephen Hurst Resigns from MindMed Board of Directors

Load more